Global Blood: 3Q Earnings Snapshot

November 7, 2018

SOUTH SAN FRANCISCO, Calif. (AP) _ Global Blood Therapeutics Inc. (GBT) on Tuesday reported a loss of $43.1 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 83 cents.

The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share.

Global Blood shares have increased roughly 1 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $39.64, a drop of roughly 5 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GBT at https://www.zacks.com/ap/GBT

Update hourly